Dx&Vx Signs USD 220 Million Co-Development And License Agreement For Mrna Cancer Vaccine With U.S. Biotech Company

TradingKey - Nike has undergone one of the greatest sentiment shifts among global consumer brands in the last 12 months.

TradingKey - For any investor with a budget, having ownership of a stock under $30 (or a stock price less than $30) is a good way of spreading out their money. 

TradingKey - For a while, talk of a U.S. recession had slipped quietly into the background, replaced by a more familiar mix of inflation concerns and trump tariffs. Now, it is back at the centre of the conversation.

TradingKey - As artificial intelligence transforms industries and adds to the volatility of markets, investors want names that can help smooth that out without sacrificing growth. The best dividend stocks can help with that objective by combining resilient cash flows with prudent capital allocation.

TradingKey - On March 16 local time, Nvidia's (NVDA) annual developer conference, GTC 2026, kicked off at the SAP Center in San Jose. As more than 30,000 developers flooded the venue, the centerpiece of this premier AI industry event was undoubtedly founder and CEO Jensen Huang’s two-and-a-half-hour